Home
About
Publications Trends
Recent Publications
Expert Search
Archive
topical applications
Who Can Benefit From Topical Applications?
Topical applications are generally recommended for patients with:
Superficial skin cancers like basal cell carcinoma
Actinic keratosis
Certain types of
cutaneous T-cell lymphoma
These treatments are especially beneficial for patients who may not be good candidates for surgical interventions due to age, comorbidities, or the location of the cancer.
Frequently asked queries:
What Are Topical Applications in Cancer Treatment?
How Effective Are Topical Applications?
Who Can Benefit From Topical Applications?
Can Hepatitis B and C be Treated?
What are Physical Therapies?
How Does Geographical Isolation Affect Cancer Incidence?
How to Choose the Right Disability Attorney?
How Do Tumors Influence Blood Supply?
What research is ongoing in the field of NBS and cancer?
What are the Challenges in Implementing a Cancer Care Plan?
Who Can Be a Patient Navigator?
Why is a PICC Line Used in Cancer Treatment?
Why do these side effects occur?
How to Manage References Efficiently?
How are Teratomas Diagnosed?
Which Types of Cancer are More Common in Men?
Why are IADLs Significant for Cancer Patients?
What are the approaches for managing peripheral neuropathy?
Why is Financial Toxicity a Concern?
What Are the Rewards of Being an Oncologist?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Lung Cancer
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
Keratinocyte
Lipid-based nanoparticles
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe